RhumbLine Advisers’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.42M | Buy |
|
|||||
|
2019
Q4 | $2.23M | Buy |
|
|||||
|
2019
Q3 | $965K | Buy |
|
|||||
|
2019
Q2 | $1.15M | Buy |
|
|||||
|
2019
Q1 | $575K | Buy |
|
|||||
|
2018
Q4 | $377K | Buy |
|
|||||
|
2018
Q3 | $259K | Buy |
|
|||||
|
2018
Q2 | $141K | Buy |
|
|||||
|
2018
Q1 | $65K | Buy |
|
|||||
|
2017
Q4 | $91K | Sell |
|
|||||
|
2017
Q3 | $190K | Buy |
|
|||||
|
2017
Q2 | $241K | Buy |
|